Abstract:Influenza A virus (IAV) is a threat to public health due to its high mutation rate and resistance to existing drugs. In this investigation, 15 targets selected from an influenza virus-host interaction network were successfully constructed as a multitarget virtual screening system for new drug discovery against IAV using Naïve Bayesian, recursive partitioning, and CDOCKER methods. The predictive accuracies of the models were evaluated using training sets and test sets. The system was then used to predict active constituents of Compound Yizhihao (CYZH), a Chinese medicinal compound used to treat influenza. Twenty-eight compounds with multitarget activities were selected for subsequent in vitro evaluation. Of the four compounds predicted to be active on neuraminidase (NA), chlorogenic acid, and orientin showed inhibitory activity in vitro. Linarin, sinensetin, cedar acid, isoliquiritigenin, sinigrin, luteolin, chlorogenic acid, orientin, epigoitrin, and rupestonic acid exhibited significant effects on TNF-α expression, which is almost consistent with predicted results. Results from a cytopathic effect (CPE) reduction assay revealed acacetin, indirubin, tryptanthrin, quercetin, luteolin, emodin, and apigenin had protective effects against wild-type strains of IAV. Quercetin, luteolin, and apigenin had good efficacy against resistant IAV strains in CPE reduction assays. Finally, with the aid of Gene Ontology biological process analysis, the potential mechanisms of CYZH action were revealed. In conclusion, a compound-protein interaction-prediction system was an efficient tool for the discovery of novel compounds against influenza, and the findings from CYZH provide important information for its usage and development.

Finding a Maximum Common Subgraph from Molecular Structural Formulas through the Maximum Clique Approach Combined with the Ising Model

Finding Largest Common Substructures of Molecules in Quadratic Time

A novel method for inference of chemical compounds with prescribed topological substructures based on integer programming

Develop integration modeling approach for discovery neuraminidase inhibitors in silico based on pharmacophore and CoMSIA models

Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico.

Solving Maximum Clique Problem for Protein Structure Similarity

Improved Dynamics for the Maximum Common Subgraph Problem

A genetic approach to the maximum common subgraph problem

The Wreaths of KHAN: Uniform Graph Feature Selection with False Discovery Rate Control

Residue-based Design of Small Molecule Inhibitor for H1N1, H5N1 and H7N1 Mutants

Discovery of Multitarget-Directed Ligands Against Influenza A Virus From Compound Yizhihao Through a Predictive System for Compound-Protein Interactions

A Surface-Based Dna Algorithm For The Maximal Clique Problem

Three Dimensional Quantitative Structure-activity Relationship of Cyclohexene Neuraminidase Inhibitors

Parallel maximal common subgraphs with labels for molecular biology

Design, synthesis, bioactivity, and DFT calculation of 2-thiazolyl-hydrazone derivatives as influenza neuraminidase inhibitors

Novel Dual‐Site‐Binding Neuraminidase Inhibitor from Virtual Screening by Pharmacophore and Molecular Dynamics Methods

Molecular Docking, 3d-Qsar Studies, And In Silico Adme Prediction Of P-Aminosalicylic Acid Derivatives As Neuraminidase Inhibitors

An integrated ligand-based modelling approach to explore the structure-property relationships of influenza endonuclease inhibitors

Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico

Modular Biomimetic Strategy Enables Discovery and SAR Exploration of Oxime Macrocycles as Influenza A Virus (H1N1) Inhibitors

MedChemExpress compounds prevent neuraminidase N1 via physics- and knowledge-based methods